Repaglinide
- Product NDC
- 62135-946
- 11-digit product format
- 621350946
- Labeler code
- 62135
- Product ID
- 62135-946_342983dc-ded9-2234-e063-6294a90ac97f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA078555
- Marketing category
- ANDA
- Marketing start
- 2013-11-22
- Substance
- REPAGLINIDE
- Active strength
- .5 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 668Z8C33LU | REPAGLINIDE | 135062-02-1 | REPAGLINIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-946-90 | 62135094690 | 90 TABLET in 1 BOTTLE (62135-946-90) | 90 tablet | 2025-04-24 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Repaglinide | Chartwell RX, LLC | 2025-05-02 | HUMAN PRESCRIPTION DRUG LABEL | 1 |